NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 20 filers reported holding NEPHROS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,338 | -7.9% | 186,039 | -3.6% | 0.11% | -1.7% |
| Q2 2023 | $299,056 | +43.9% | 192,939 | -0.7% | 0.12% | +34.9% |
| Q1 2023 | $207,870 | -7.8% | 194,289 | -0.3% | 0.09% | -11.3% |
| Q4 2022 | $225,410 | -1.6% | 194,789 | -22.7% | 0.10% | -5.8% |
| Q3 2022 | $229,000 | -43.3% | 252,124 | -4.4% | 0.10% | -40.5% |
| Q2 2022 | $404,000 | -62.7% | 263,754 | +7.0% | 0.17% | -54.7% |
| Q1 2022 | $1,084,000 | -21.0% | 246,408 | +6.0% | 0.38% | -15.3% |
| Q4 2021 | $1,372,000 | -33.2% | 232,508 | -0.7% | 0.45% | -35.0% |
| Q3 2021 | $2,054,000 | -12.6% | 234,208 | +1.2% | 0.69% | -9.8% |
| Q2 2021 | $2,350,000 | +61.1% | 231,508 | +5.5% | 0.77% | +45.9% |
| Q1 2021 | $1,459,000 | -83.6% | 219,378 | -78.8% | 0.53% | -24.8% |
| Q4 2020 | $8,875,000 | +21.7% | 1,034,240 | +2.5% | 0.70% | -9.4% |
| Q3 2020 | $7,295,000 | -14.1% | 1,008,990 | -0.3% | 0.77% | -17.9% |
| Q2 2020 | $8,495,000 | +221.8% | 1,012,345 | +387.7% | 0.94% | -51.5% |
| Q1 2020 | $2,640,000 | – | 207,569 | – | 1.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEXFORD CAPITAL LP | 3,395,579 | $21,391,000 | 7.91% |
| BARD ASSOCIATES INC | 207,569 | $2,640,000 | 1.94% |
| Parkman Healthcare Partners LLC | 251,366 | $1,584,000 | 0.73% |
| Cowen Prime Services LLC | 154,800 | $975,000 | 0.60% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 12,957 | $82,000 | 0.07% |
| INGALLS & SNYDER LLC | 133,140 | $839,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 39,863 | $251,000 | 0.05% |
| B. Riley Wealth Advisors, Inc. | 14,428 | $91,000 | 0.01% |
| HighTower Advisors, LLC | 43,210 | $273,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 34,249 | $216,000 | 0.00% |